Gene · 3984
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms of Long Non-Coding RNA in Breast Cancer. | Int J Mol Sci | 2023 | 36901971 | PubTator, text mining | PubMed |
| Comprehensive Analyses and Immunophenotyping of LIM Domain Family Genes in Patients with Non-Small-Cell Lung Cancer. | Int J Mol Sci | 2023 | 36901953 | PubTator, text mining | PubMed |
| Nogo-A and LINGO-1: Two Important Targets for Remyelination and Regeneration. | Int J Mol Sci | 2023 | 36901909 | PubTator, text mining | PubMed |
| LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. | Cells | 2023 | 36899941 | PubTator, text mining | PubMed |
| Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2. | iScience | 2023 | 36890793 | PubTator, text mining | PubMed |
| RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis. | Front Neurosci | 2023 | 36875672 | PubTator, text mining | PubMed |
| Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer. | Front Immunol | 2023 | 36865554 | PubTator, text mining | PubMed |
| The emerging role of microtubules in invasion plasticity. | Front Oncol | 2023 | 36860323 | PubTator, text mining | PubMed |
| From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment. | J Med Chem | 2023 | 36858050 | PubTator, text mining | PubMed |
| Advances in the Development of Small Molecule Antivirals against Equine Encephalitic Viruses. | Viruses | 2023 | 36851628 | PubTator, text mining | PubMed |
| Identification of Five Tumor Antigens for Development and Two Immune Subtypes for Personalized Medicine of mRNA Vaccines in Papillary Renal Cell Carcinoma. | J Pers Med | 2023 | 36836593 | PubTator, text mining | PubMed |
| The Dual Function of RhoGDI2 in Immunity and Cancer. | Int J Mol Sci | 2023 | 36835422 | PubTator, text mining | PubMed |
| Dental Phenotype with Minor Ectodermal Symptoms Suggestive of WNT10A Deficiency. | Children (Basel) | 2023 | 36832485 | PubTator, text mining | PubMed |
| Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics. | Cells | 2023 | 36831201 | PubTator, text mining | PubMed |
| Hyperactivation of p21-Activated Kinases in Human Cancer and Therapeutic Sensitivity. | Biomedicines | 2023 | 36830998 | PubTator, text mining | PubMed |
| RhoGDIα regulates spermatogenesis through Rac1/cofilin/F-actin signaling. | Commun Biol | 2023 | 36823181 | PubTator, text mining | PubMed |
| XTP1 facilitates the growth and development of gastric cancer by activating CDK6. | Ann Transl Med | 2023 | 36819538 | PubTator, text mining | PubMed |
| Predicting IHC staining classes of NF1 using features in the hematoxylin channel. | J Pathol Inform | 2023 | 36814440 | PubTator, text mining | PubMed |
| Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. | Mol Ther | 2023 | 36805147 | PubTator, text mining | PubMed |
| Diallyl disulfide downregulating RhoGDI2 induces differentiation and inhibit invasion via the Rac1/Pak1/LIMK1 pathway in human leukemia HL-60 cells. | Environ Toxicol | 2023 | 36793247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3984/papers?page=15